(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 16.13% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Personalis's revenue in 2025 is $85,694,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2025 to be $7,445,985,784, with the lowest PSNL revenue forecast at $7,340,525,569, and the highest PSNL revenue forecast at $7,587,129,354. On average, 3 Wall Street analysts forecast PSNL's revenue for 2026 to be $9,211,251,992, with the lowest PSNL revenue forecast at $9,062,159,159, and the highest PSNL revenue forecast at $9,385,782,464.
In 2027, PSNL is forecast to generate $12,116,000,805 in revenue, with the lowest revenue forecast at $11,585,608,351 and the highest revenue forecast at $12,646,393,259.